Solventum earnings were $156.0M for the trailing 12 months ending Sep 30, 2026, with -89.8% growth year over year. The latest SOLV earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$12.0M, down 113% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SOLV reported annual earnings of $1.6B, with 224.8% growth.
SOLV past earnings growth
How has SOLV's earnings growth performed historically?
On SOLV's earnings call on Nov 5, 2026, Solventum (NYSE: SOLV) reported Q3 2026 earnings per share (EPS) of -$0.07, up 100.96% year over year. Total SOLV earnings for the quarter were -$12.00 million. In the same quarter last year, Solventum's earnings per share (EPS) was $7.26.
As of the last Solventum earnings report, Solventum is currently profitable. Solventum's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $156.00 million, a 89.76% decrease year over year.
What was SOLV's earnings growth in the past year?
As of Solventum's earnings date in Nov 5, 2026, Solventum's earnings has grown -89.83% year over year. This is 108.11 percentage points lower than the US Health Information Services industry earnings growth rate of 18.28%. SOLV earnings in the past year totalled $156.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.